IL1B and myeloid sarcoma: In summary, a reduced capacity of macrophages to generated 25-HC may result in enhanced activity of the mevalonate pathway leading to over production of Il1b, and to reduced LXR activation which will both lead to enhanced inflammatory activity of macrophages recruited to the CNS in MS.